The Doris Duke Charitable Foundation has announced the recipients of its 2022 Clinical Scientist Development Awards.

This year’s cohort of 16 early-career physician-scientist faculty will receive grants of $495,000 over three years to advance the prevention, diagnosis, and treatment of human disease and support recipients’ transition to independent research careers. Since 1998, the foundation has awarded nearly $170 million to advance the clinical research of early-career scientists, enabling them to dedicate and protect 75 percent of their time toward clinical research and encouraging the development of strong mentorship relations in supportive institutional environments.

This year, more than half of the researchers (53 percent) are women and 23 percent identify as Black or Hispanic/Latinx. A large share of this year’s recipients propose work in health outcomes, treatment, and prevention, marking an increase from previous years, and span a broad range of critical health issues including, but not limited to, cardiology, telehealth care delivery, substance use disorder treatment, oncology and mental health.

“We are excited to support this group of Clinical Scientist Development Awardees, whose research projects encompass highly significant questions, approaches and insights yielded from their interactions with patients and the healthcare system,” said Sindy Escobar Alvarez, director for medical research at the foundation. “Whether improving understanding of disease mechanisms or illuminating insights into access to care, their contributions to the biomedical field are invaluable, and we look forward to following their important work.” 

For a complete list of this year’s awardees, see the DDCF website.

(Photo credit: Getty Images/gorodenkoff)